Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?

AIM: Digoxin is considered contraindicated in light-chain (AL) amyloidosis, given reports of increased toxicity published 30–50 years ago. We sought to determine the frequency of digoxin toxicity in patients with AL. METHODS: We identified 107 patients with AL amyloidosis who received digoxin betwee...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Amyloid
Main Authors: Muchtar, Eli, Gertz, Morie A., Kumar, Shaji K., Lin, Grace, Boilson, Barry, Clavell, Alfredo, Lacy, Martha Q., Buadi, Francis K., Hayman, Suzanne R., Kapoor, Prashant, Dingli, David, Rajkumar, S. Vincent, Dispenzieri, Angela, Grogan, Martha
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7433245/
https://ncbi.nlm.nih.gov/pubmed/29529877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13506129.2018.1449744
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares